Copper(II) complexes with 2NO and 3N donor ligands: synthesis, structures and chemical nuclease and anticancer activities. 2013

Chandrasekaran Rajarajeswari, and Rangasamy Loganathan, and Mallayan Palaniandavar, and Eringathodi Suresh, and Anvarbatcha Riyasdeen, and Mohamad Abdulkadhar Akbarsha
School of Chemistry, Bharathidasan University, Tiruchirappalli-620 024, Tamil Nadu, India.

A series of water soluble copper(II) complexes of the types [Cu(L)Cl] 1-2, where LH is 2-(2-(1H-benzimidazol-2-yl)ethyliminomethyl)phenol (H(L1)), and 2-(2-(1H-benzimidazol-2-yl)-ethyliminomethyl)-4-methylphenol (H(L2)), and [Cu(L)Cl2] 3-6, where L is (2-pyridin-2-yl-ethyl)pyridin-2-ylmethyleneamine (L3), 2-(1H-benzimidazol-2-yl)ethylpyridin-2-yl-methyleneamine (L4), 2-(1H-benzimidazol-2-yl)ethyl(1H-imidazol-2-ylmethylene)amine (L5), and 2-(1H-benzimidazol-2-yl)ethyl-(4,4a-dihydroquinolin-2-ylmethylene)amine (L6), have been isolated and characterized by elemental analysis, electronic absorption, ESI-MS and EPR spectral techniques and the electrochemical method. The single crystal X-ray structures of [Cu(L1)Cl] 1 and [Cu(L2)Cl] 2 possess a distorted square-based coordination geometry while [Cu(L4)Cl2] 4 and [Cu(L6)Cl2] 6 possess a distorted trigonal bipyramidal coordination geometry. Both absorption spectral titration and an EthBr displacement assay reveal that all the complexes bind with calf thymus (CT) DNA through covalent mode of DNA interaction involving the replacement of an easily removable chloride ion with DNA nucleobases. All the complexes exhibit oxidative cleavage of supercoiled (SC) plasmid DNA in the presence of hydrogen peroxide as an activator. It is remarkable that at 50 μM concentration 5 and 6 completely degrade SC DNA into undetectable minor fragments and thus they act as efficient chemical nucleases. All the complexes are remarkable in displaying cytotoxicity against the HBL-100 human breast cancer cell line with potency more than that of the widely used drug cisplatin and hence they have the potential to act as promising anticancer drugs. Interestingly, they are non-toxic to normal cell lymphocytes isolated from human blood samples, revealing that they are selective in killing only the cancer cells.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D009584 Nitrogen An element with the atomic symbol N, atomic number 7, and atomic weight [14.00643; 14.00728]. Nitrogen exists as a diatomic gas and makes up about 78% of the earth's atmosphere by volume. It is a constituent of proteins and nucleic acids and found in all living cells.
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D003300 Copper A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55. Copper-63,Copper 63
D003851 Deoxyribonucleases Enzymes which catalyze the hydrolases of ester bonds within DNA. EC 3.1.-. DNAase,DNase,Deoxyribonuclease,Desoxyribonuclease,Desoxyribonucleases,Nucleases, DNA,Acid DNase,Alkaline DNase,DNA Nucleases,DNase, Acid,DNase, Alkaline
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

Chandrasekaran Rajarajeswari, and Rangasamy Loganathan, and Mallayan Palaniandavar, and Eringathodi Suresh, and Anvarbatcha Riyasdeen, and Mohamad Abdulkadhar Akbarsha
December 2019, Dalton transactions (Cambridge, England : 2003),
Chandrasekaran Rajarajeswari, and Rangasamy Loganathan, and Mallayan Palaniandavar, and Eringathodi Suresh, and Anvarbatcha Riyasdeen, and Mohamad Abdulkadhar Akbarsha
October 2022, Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine,
Chandrasekaran Rajarajeswari, and Rangasamy Loganathan, and Mallayan Palaniandavar, and Eringathodi Suresh, and Anvarbatcha Riyasdeen, and Mohamad Abdulkadhar Akbarsha
May 2023, Dalton transactions (Cambridge, England : 2003),
Chandrasekaran Rajarajeswari, and Rangasamy Loganathan, and Mallayan Palaniandavar, and Eringathodi Suresh, and Anvarbatcha Riyasdeen, and Mohamad Abdulkadhar Akbarsha
April 2014, Dalton transactions (Cambridge, England : 2003),
Chandrasekaran Rajarajeswari, and Rangasamy Loganathan, and Mallayan Palaniandavar, and Eringathodi Suresh, and Anvarbatcha Riyasdeen, and Mohamad Abdulkadhar Akbarsha
March 2012, Journal of inorganic biochemistry,
Chandrasekaran Rajarajeswari, and Rangasamy Loganathan, and Mallayan Palaniandavar, and Eringathodi Suresh, and Anvarbatcha Riyasdeen, and Mohamad Abdulkadhar Akbarsha
February 2018, Journal of inorganic biochemistry,
Chandrasekaran Rajarajeswari, and Rangasamy Loganathan, and Mallayan Palaniandavar, and Eringathodi Suresh, and Anvarbatcha Riyasdeen, and Mohamad Abdulkadhar Akbarsha
October 2019, Dalton transactions (Cambridge, England : 2003),
Chandrasekaran Rajarajeswari, and Rangasamy Loganathan, and Mallayan Palaniandavar, and Eringathodi Suresh, and Anvarbatcha Riyasdeen, and Mohamad Abdulkadhar Akbarsha
October 2004, Inorganic chemistry,
Chandrasekaran Rajarajeswari, and Rangasamy Loganathan, and Mallayan Palaniandavar, and Eringathodi Suresh, and Anvarbatcha Riyasdeen, and Mohamad Abdulkadhar Akbarsha
August 2013, Dalton transactions (Cambridge, England : 2003),
Chandrasekaran Rajarajeswari, and Rangasamy Loganathan, and Mallayan Palaniandavar, and Eringathodi Suresh, and Anvarbatcha Riyasdeen, and Mohamad Abdulkadhar Akbarsha
March 2004, Journal of inorganic biochemistry,
Copied contents to your clipboard!